BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND ETV4, PEA3, 2118, ENSG00000175832, E1AF, E1A-F, PEAS3 AND Treatment
8 results:

  • 1. Immunophenotyping characteristics and outcome of COVID-19 patients: peripheral blood CD8+T cell as a prognostic biomarker for patients with Nirmatrelvir.
    Sun Y; Dian Y; Gao Q; Deng G
    Front Immunol; 2023; 14():1227905. PubMed ID: 37799722
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19: A retrospective cohort study.
    Deng G; Li D; Sun Y; Jin L; Zhou Q; Xiao C; Wu Q; Sun H; Dian Y; Zeng F; Pan P; Shen M
    J Med Virol; 2023 Apr; 95(4):e28756. PubMed ID: 37185838
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Dual-specificity protein phosphatase DUSP4 regulates response to MEK inhibition in BRAF wild-type melanoma.
    Gupta A; Towers C; Willenbrock F; Brant R; Hodgson DR; Sharpe A; Smith P; Cutts A; Schuh A; Asher R; Myers K; Love S; Collins L; Wise A; Middleton MR; Macaulay VM
    Br J Cancer; 2020 Feb; 122(4):506-516. PubMed ID: 31839677
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion.
    Chen Y; Sumardika IW; Tomonobu N; Winarsa Ruma IM; Kinoshita R; Kondo E; Inoue Y; Sato H; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Liu M; Futami J; Sasai K; Katayama H; Kubo M; Putranto EW; Hibino T; Sun B; Nishibori M; Toyooka S; Sakaguchi M
    Cancer Lett; 2019 Jun; 452():178-190. PubMed ID: 30904617
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors.
    Xie Y; Cao Z; Wong EW; Guan Y; Ma W; Zhang JQ; Walczak EG; Murphy D; Ran L; Sirota I; Wang S; Shukla S; Gao D; Knott SR; Chang K; Leu J; Wongvipat J; Antonescu CR; Hannon G; Chi P; Chen Y
    J Clin Invest; 2018 Apr; 128(4):1442-1457. PubMed ID: 29360641
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mechanisms and strategies to overcome resistance to molecularly targeted therapy for melanoma.
    Lim SY; Menzies AM; Rizos H
    Cancer; 2017 Jun; 123(S11):2118-2129. PubMed ID: 28543695
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The changing face of dermatological practice: 25 years' experience.
    Benton EC; Kerr OA; Fisher A; Fraser SJ; McCormack SK; Tidman MJ
    Br J Dermatol; 2008 Aug; 159(2):413-8. PubMed ID: 18565175
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cutaneous uretero-ureterostomy: a technique of urinary diversion for high-risk patients with bladder cancer.
    Shafik A; Shafik IA; El Sibai O
    Surg Technol Int; 2007; 16():151-5. PubMed ID: 17429783
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.